Clinical trial · Interventional
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Efficacy and Safety Assessment of Single-port Versus Multi-port Robotic Surgery for Rectal Cancer: a Phase 2 Non-randomized Controlled Study Based on the IDEAL Framework
NCT06824688CI-TRIAL-00120560recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Single-port versus multi-port robotic surgery for rectal cancer
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Cancer Patients | — | UNRESOLVED | — |
| Robotic Surgical Procedures | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multi-port robotic total mesorectal excision | Procedure | — | UNRESOLVED |
| Single-port robotic total mesorectal excision | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Single-port robotic total mesorectal excision
- description
- Single-port robotic total mesorectal excision
- interventionNames
- Procedure: Single-port robotic total mesorectal excision
- type
- ACTIVE_COMPARATOR
- label
- Multi-port robotic total mesorectal excision
- description
- Multi-port robotic total mesorectal excision
- interventionNames
- Procedure: Multi-port robotic total mesorectal excision
Primary outcomes (2)
- measure
- Incidence of perioperative complications
- timeFrame
- Intraoperative and postoperative 30 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria comprised: (1) MRI-confirmed distal tumor margin \<15 cm from the anal verge, (2) biopsy-proven adenocarcinoma, (3) clinical stage I-III (AJCC 8th edition) with potential downstaging post-neoadjuvant therapy, (4) intent-to-treat with sphincter preservation and primary anastomosis, (5) documented informed consent, and (6) adult patients (≥18 years).
References
Publications (0)
Data not yet available
No reference posted for this study.